Literature DB >> 27834031

Surgeon's Experience Overrides the Effect of Hospital Volume for Postoperative Outcomes of Laparoscopic Surgery in Gastric Cancer: Multi-institutional Study.

Han Hong Lee1, Sang-Yong Son2, Ju Hee Lee3, Min Gyu Kim4, Hoon Hur2, Do Joong Park5.   

Abstract

BACKGROUND: Hospital volume is known to be a crucial factor in reducing postoperative morbidity and mortality in laparoscopic gastrectomy for gastric cancer. However, it is unclear whether surgeon's individual experience can overcome the effect of hospital volume.
METHODS: Clinicopathologic data of initial 50 laparoscopic gastrectomy cases were collected from six gastric cancer surgeons. Half of the six surgeons worked in high-volume centers, and the other half worked in low-volume hospitals. Perioperative outcomes were compared between the high-volume centers and the low-volume hospitals.
RESULTS: Three low-volume hospitals in this study contained significantly more male and older patients with a higher American Society of Anesthesiologists score than high-volume centers. Although high- and low-volume hospitals mainly used laparoscopy-assisted and totally laparoscopic approach, respectively, there were no differences between the two groups in the extent of resection, operating time, estimated blood loss, and number of collected lymph nodes. Postoperative recovery such as duration to soft diet and hospital stay did not differ between the high- and the low-volume hospitals. No significant difference was found in postoperative morbidities by Clavien-Dindo classification. There was no mortality reported in both groups of the enrolled hospitals.
CONCLUSIONS: Hospital volume is not a decisive factor in affecting postoperative morbidity and mortality for well-trained beginners in laparoscopic surgery for gastric cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27834031     DOI: 10.1245/s10434-016-5672-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Laparoscopic versus open resection for elderly patients with gastric cancer: a double-center study with propensity score matching method.

Authors:  Wei-Zhe Chen; Qian-Tong Dong; Feng-Min Zhang; Hui-Yang Cai; Jing-Yi Yan; Cheng-Le Zhuang; Zhen Yu; Xiao-Lei Chen
Journal:  Langenbecks Arch Surg       Date:  2020-09-03       Impact factor: 3.445

2.  The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer.

Authors:  Ivy N Haskins; Matthew D Kroh; Richard L Amdur; Jeffrey L Ponksy; John H Rodriguez; Khashayar Vaziri
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

3.  Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan; Haibo Wang
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

Review 4.  Associations of Annual Hospital and Surgeon Volume with Patient Outcomes After Gastrectomy: A Systematic Review and Meta-analysis.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan
Journal:  Ann Surg Oncol       Date:  2022-09-15       Impact factor: 4.339

5.  First experience of junior surgeons with laparoscopic distal gastrectomy: in view of comparison with experienced surgeons.

Authors:  Ki Bum Park; Yoontaek Lee; Dong-Wook Kim
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-09-24       Impact factor: 1.195

6.  Perforation on the superior side of duodenum is a risk factor of laparoscopic primary repair for duodenal ulcer perforation.

Authors:  Hyun Il Kim; Yu Jeong Cho; Jong Hoon Yeom; Woo Jae Jeon; Min Gyu Kim
Journal:  Ann Surg Treat Res       Date:  2021-03-30       Impact factor: 1.859

7.  Disparities in major surgery for esophagogastric cancer among hospitals by case volume.

Authors:  Emmanuel Gabriel; Sumana Narayanan; Kristopher Attwood; Steven Hochwald; Moshim Kukar; Steven Nurkin
Journal:  J Gastrointest Oncol       Date:  2018-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.